Neural Therapeutics Inc. (CSE:NURL)

Neural Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is August - July.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jul 9, 2025	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022
Debt / Equity Ratio	-1.24	-0.56	-0.53	-
Quick Ratio	1.70	0.31	0.72	0.91
Current Ratio	1.84	0.31	0.74	0.98
Return on Assets (ROA)	-240.21%	-183.08%	-186.98%	-
Buyback Yield / Dilution	-22.59%	-58.39%	-7.98%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.